Skip to main content
. 2024 Nov 16;12(6):169. doi: 10.3390/pharmacy12060169

Table 2.

Patients eligible for telepharmacy.

Responses N
Common diseases in users (multiple responses) Chronic diseases (lifestyle diseases, etc.) 8
COVID-19 2
Psychiatric disorders 1
Chemotherapy 1
Age group with the highest number of users 20–30s 2
40–50s 6
60–70s 1
≥80s 2